[1] |
WANG C, JING J, CHENG L. Emerging roles of non-coding RNAs in the pathogenesis,diagnosis and prognosis of osteosarcoma[J]. Invest New Drugs, 2018, 36(6):1116-1132.
DOI
|
[2] |
HARRISON D J, GELLER D S, GILL J D, et al. Current and future therapeutic approaches for osteosarcoma[J]. Expert Rev Anticancer Ther, 2018, 18(1):39-50.
DOI
URL
|
[3] |
廖健宏, 秦琼. 骨肉瘤发病相关因素的研究进展[J]. 癌症进展, 2020, 18(14):1413-1416.
|
[4] |
金正, 崔京钦, 曾一平, 等. 环状RNA circ_0002052在骨肉瘤组织中的表达及临床意义[J]. 中华实用诊断与治疗杂志, 2019, 33(1):32-34.
|
[5] |
VAFADAR A, SHABANINEJAD Z, MOVAHEDPOUR A, et al. Long non-coding RNAs as epigenetic regulators in cancer[J]. Curr Pharm Des, 2019, 25(33):3563-3577.
DOI
URL
|
[6] |
DYKES I M, EMANUELI C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA[J]. Genomics Proteomics Bioinformatics, 2017, 15(3):177-186.
DOI
URL
|
[7] |
SANCHEZ CALLE A, KAWAMURA Y, YAMAMOTO Y, et al. Emerging roles of long non-coding RNA in cancer[J]. Cancer Sci, 2018, 109(7):2093-2100.
DOI
URL
|
[8] |
王晓琼, 蔡志毅. 长链非编码RNA ZFAS1在肿瘤中的研究进展[J]. 现代肿瘤医学, 2019, 27(3):537-540.
|
[9] |
熊齐胜, 韩迎祥, 汪学松, 等. 骨肉瘤的分化疗法与研究进展[J]. 中国现代医学杂志, 2020, 30(11):48-51.
|
[10] |
张健烽, 刘云霞. 骨肉瘤治疗的研究进展[J]. 浙江医学, 2019, 41(7):723-727.
|
[11] |
TAÇYILDIZ N, UNAL E, DINÇASLAN H, et al. Muramyl tripeptide plus chemotherapy reduces metastasis in non-metastatic osteosarcoma:a single-center experience[J]. Asian Pac J Cancer Prev, 2020, 21(3):715-720.
DOI
URL
|
[12] |
LI Z, DOU P, LIU T, et al. Application of long noncoding RNAs in osteosarcoma:biomarkers and therapeutic targets[J]. Cell Physiol Biochem, 2017, 42(4):1407-1419.
DOI
URL
|
[13] |
FU D, LU C, QU X, et al. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis[J]. Aging(Albany NY), 2019, 11(19):8374-8385.
|
[14] |
徐鑫令, 侯乃方, 王欣玲. 长链非编码RNA在眼部疾病中的作用[J]. 国际眼科杂志, 2020, 20(10):1719-1721.
|
[15] |
SHENG K, LI Y. LncRNA TUG1 promotes the development of osteosarcoma through RUNX2[J]. Exp Ther Med, 2019, 18(4):3002-3008.
DOI
PMID
|
[16] |
李彦儒, 焦磊, 张莹, 等. 长链非编码RNA——锌指蛋白反义链1的研究现状[J]. 中国临床药理学杂志, 2017, 33(22):2314-2317.
|
[17] |
LIANG L, ZHANG Z, QIN X, et al. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma[J]. Melanoma Res, 2019, 29(6):569-581.
DOI
PMID
|
[18] |
LI Z, JIANG X, HUANG L, et al. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p[J]. J Cell Mol Med, 2019, 23(12):8258-8268.
DOI
PMID
|
[19] |
FENG L L, SHEN F R, ZHOU J H, et al. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity[J]. Gene, 2019, 696:105-112.
DOI
URL
|
[20] |
HAN C G, HUANG Y, QIN L. Long non-coding RNA ZFAS1 as a novel potential biomarker for predicting the prognosis of thyroid cancer[J]. Med Sci Monit, 2019, 25:2984-2992.
DOI
URL
|